X4 PHARMACEUTICALS INC's ticker is XFOR and the CUSIP is 98420X103. A total of 60 filers reported holding X4 PHARMACEUTICALS INC in Q1 2023. The put-call ratio across all filers is 2.88 and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $14 | -96.8% | 13,280 | -94.1% | 0.00% | – |
| Q2 2023 | $439 | +1467.9% | 226,566 | +591.0% | 0.00% | – |
| Q1 2023 | $28 | +55.6% | 32,788 | +78.9% | 0.00% | – |
| Q4 2022 | $18 | -99.9% | 18,324 | +63.1% | 0.00% | – |
| Q3 2022 | $19,000 | -69.4% | 11,237 | -68.5% | 0.00% | – |
| Q1 2022 | $62,000 | +416.7% | 35,673 | +571.9% | 0.00% | – |
| Q4 2021 | $12,000 | – | 5,309 | +9917.0% | 0.00% | – |
| Q3 2021 | $0 | – | 53 | 0.0% | 0.00% | – |
| Q2 2021 | $0 | – | 53 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Bain Capital Life Sciences Investors, LLC | 12,202,510 | $10,616 | 1.33% |
| Tri Locum Partners LP | 3,878,484 | $3,374,281 | 1.03% |
| Lynwood Capital Management Inc. | 900,000 | $783,000 | 0.71% |
| NEA Management Company, LLC | 11,736,793 | $10,211,010 | 0.71% |
| Parkman Healthcare Partners LLC | 2,797,147 | $2,433,518 | 0.53% |
| SCOGGIN MANAGEMENT LP | 484,796 | $567,025 | 0.33% |
| New Leaf Venture Partners, L.L.C. | 335,000 | $291,450 | 0.24% |
| Ghost Tree Capital, LLC | 850,000 | $740,000 | 0.22% |
| Perceptive Advisors | 4,545,454 | $3,954,545 | 0.12% |
| Orbimed Advisors | 5,817,726 | $5,061,422 | 0.10% |